Analysis of cyclin B1 and CDK activity during apoptosis induced by camptothecin treatment.

Borgne, A; Versteege, I; Mahé, M; Studeny, A; Léonce, S; Naime, I; Rodriguez, M; Hickman, J A; Meijer, L; Golsteyn, R M

Borgne, A; Versteege, I; Mahé, M; Studeny, A; Léonce, S; Naime, I; Rodriguez, M; Hickman, J A; Meijer, L; Golsteyn, R M.

Affiliation

Borgne A; Institut de Recherches Servier, Cancer Drug Discovery, Croissy-sur-Seine, France.

Oncogene ; 25(56): 7361-72, 2006 Nov 30.

Article in En | MEDLINE | ID: mdl-16785996

Subject(s)

Antineoplastic Agents, Phytogenic/pharmacology; Apoptosis/drug effects; Camptothecin/pharmacology; Cyclin B/metabolism; Cyclin-Dependent Kinases/metabolism; Base Sequence; Cell Cycle; Cyclin A/metabolism; Cyclin B1; Cyclin E/metabolism; DNA Primers; Electrophoresis, Polyacrylamide Gel; Fluorescent Antibody Technique; HT29 Cells; Humans; RNA Interference

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Camptothecin / Apoptosis / Cyclin-Dependent Kinases / Cyclin B / Antineoplastic Agents, Phytogenic Limits: Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2006 Type: Article Affiliation country: France

Search on Google

Add to My VHL

XML

PubMed Links